Pandemic / Seasonal Flu Vaccine Manufacturing Technologies
As a total solutions provider, Pall is working closely with its customers to assist them with the efficient, rapid manufacture of pandemic influenza vaccines. Pall technologies are in use in the production of almost all commercially-available seasonal influenza vaccines, and utilizing this expertise and our state-of-the-art technologies, we can support our customers all the way from the development stages right through to manufacture and product release.
In addition, Pall’s Allegro™ single-use systems provide essential assistance in order to facilitate quick product manufacture and increased capacity - of critical importance during pandemic outbreaks.